Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,863,047
-
Share change
-
+130,799
-
Total reported value
-
$16,716,000
-
Price per share
-
$5.84
-
Number of holders
-
28
-
Value change
-
+$635,508
-
Number of buys
-
16
-
Number of sells
-
12
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q4 2014
As of 31 Dec 2014,
TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,863,047 shares.
The largest 10 holders included
KINGDON CAPITAL MANAGEMENT, L.L.C., Broadfin Capital, LLC, FRANKLIN RESOURCES INC, BLUESTEIN R H & CO, Lombard Odier Asset Management (USA) Corp, VANGUARD GROUP INC, WALL STREET ASSOCIATES, Integre Asset Management, LLC, MORGAN STANLEY, and ROYAL BANK OF CANADA.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.